000 | 01546 a2200421 4500 | ||
---|---|---|---|
005 | 20250514041533.0 | ||
264 | 0 | _c20030210 | |
008 | 200302s 0 0 eng d | ||
022 | _a1352-4585 | ||
024 | 7 |
_a10.1191/1352458502ms810oa _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChabot, S | |
245 | 0 | 0 |
_aCytokine production in T lymphocyte-microglia interaction is attenuated by glatiramer acetate: a mechanism for therapeutic efficacy in multiple sclerosis. _h[electronic resource] |
260 |
_bMultiple sclerosis (Houndmills, Basingstoke, England) _cAug 2002 |
||
300 |
_a299-306 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aCell Adhesion _xdrug effects |
650 | 0 | 4 |
_aCell Communication _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aCoculture Techniques |
650 | 0 | 4 |
_aCytokines _xmetabolism |
650 | 0 | 4 | _aGlatiramer Acetate |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
650 | 0 | 4 |
_aMacrophages _xcytology |
650 | 0 | 4 |
_aMicroglia _xcytology |
650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
650 | 0 | 4 |
_aPeptides _xpharmacology |
650 | 0 | 4 |
_aT-Lymphocytes _xcytology |
700 | 1 | _aYong, F P | |
700 | 1 | _aLe, D M | |
700 | 1 | _aMetz, L M | |
700 | 1 | _aMyles, T | |
700 | 1 | _aYong, V W | |
773 | 0 |
_tMultiple sclerosis (Houndmills, Basingstoke, England) _gvol. 8 _gno. 4 _gp. 299-306 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1191/1352458502ms810oa _zAvailable from publisher's website |
999 |
_c12049472 _d12049472 |